Global Targeted Antitumor Drugs Supply, Demand and Key Producers, 2024-2030

Description

The global Targeted Antitumor Drugs market size is expected to reach $ 58750 million by 2030, rising at a market growth of 6.9% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Targeted antitumor drugs use specific structural molecules of tumor tissues or cells as targets to achieve the purpose of directly killing tumor cells, and have the advantages of high specificity, high selectivity, light side reactions and high efficacy/toxicity ratio compared with chemotherapy drugs
This report studies the global Targeted Antitumor Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Targeted Antitumor Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Targeted Antitumor Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Targeted Antitumor Drugs total production and demand, 2019-2030, (K Units)
Global Targeted Antitumor Drugs total production value, 2019-2030, (USD Million)
Global Targeted Antitumor Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Targeted Antitumor Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Targeted Antitumor Drugs domestic production, consumption, key domestic manufacturers and share
Global Targeted Antitumor Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Targeted Antitumor Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Targeted Antitumor Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Targeted Antitumor Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Celgene, Novartis, Johnson & Johnson, Lilly, AstraZeneca plc., Betta Pharmaceuticals, Shanghai Henlius Biopharmaceutical and Innovent Biologics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Targeted Antitumor Drugs market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Targeted Antitumor Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Targeted Antitumor Drugs Market, Segmentation by Type
    Injection
    Tablet
    Others

Global Targeted Antitumor Drugs Market, Segmentation by Application
    Lung Cancer
    Lymphoma
    Breast Cancer
    Leukaemia
    Prostate Cancer
    Multiple Bone Marrow Cancer
    Others

Companies Profiled:
    Roche
    Celgene
    Novartis
    Johnson & Johnson
    Lilly
    AstraZeneca plc.
    Betta Pharmaceuticals
    Shanghai Henlius Biopharmaceutical
    Innovent Biologics
    Nanjing Shunxin Pharmaceuticals
    CSPC OUYI Pharmaceutical
    Qilu Pharmaceutical
    Shenzhen Salubris Pharmaceuticals
    Yaopharma
    Lianyungang Runzhong Pharmaceutical

Key Questions Answered
1. How big is the global Targeted Antitumor Drugs market?
2. What is the demand of the global Targeted Antitumor Drugs market?
3. What is the year over year growth of the global Targeted Antitumor Drugs market?
4. What is the production and production value of the global Targeted Antitumor Drugs market?
5. Who are the key producers in the global Targeted Antitumor Drugs market?

Table of Contents

1 Supply Summary
    1.1 Targeted Antitumor Drugs Introduction
    1.2 World Targeted Antitumor Drugs Supply & Forecast
        1.2.1 World Targeted Antitumor Drugs Production Value (2019 & 2023 & 2030)
        1.2.2 World Targeted Antitumor Drugs Production (2019-2030)
        1.2.3 World Targeted Antitumor Drugs Pricing Trends (2019-2030)
    1.3 World Targeted Antitumor Drugs Production by Region (Based on Production Site)
        1.3.1 World Targeted Antitumor Drugs Production Value by Region (2019-2030)
        1.3.2 World Targeted Antitumor Drugs Production by Region (2019-2030)
        1.3.3 World Targeted Antitumor Drugs Average Price by Region (2019-2030)
        1.3.4 North America Targeted Antitumor Drugs Production (2019-2030)
        1.3.5 Europe Targeted Antitumor Drugs Production (2019-2030)
        1.3.6 China Targeted Antitumor Drugs Production (2019-2030)
        1.3.7 Japan Targeted Antitumor Drugs Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Targeted Antitumor Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Targeted Antitumor Drugs Major Market Trends

2 Demand Summary
    2.1 World Targeted Antitumor Drugs Demand (2019-2030)
    2.2 World Targeted Antitumor Drugs Consumption by Region
        2.2.1 World Targeted Antitumor Drugs Consumption by Region (2019-2024)
        2.2.2 World Targeted Antitumor Drugs Consumption Forecast by Region (2025-2030)
    2.3 United States Targeted Antitumor Drugs Consumption (2019-2030)
    2.4 China Targeted Antitumor Drugs Consumption (2019-2030)
    2.5 Europe Targeted Antitumor Drugs Consumption (2019-2030)
    2.6 Japan Targeted Antitumor Drugs Consumption (2019-2030)
    2.7 South Korea Targeted Antitumor Drugs Consumption (2019-2030)
    2.8 ASEAN Targeted Antitumor Drugs Consumption (2019-2030)
    2.9 India Targeted Antitumor Drugs Consumption (2019-2030)

3 World Targeted Antitumor Drugs Manufacturers Competitive Analysis
    3.1 World Targeted Antitumor Drugs Production Value by Manufacturer (2019-2024)
    3.2 World Targeted Antitumor Drugs Production by Manufacturer (2019-2024)
    3.3 World Targeted Antitumor Drugs Average Price by Manufacturer (2019-2024)
    3.4 Targeted Antitumor Drugs Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Targeted Antitumor Drugs Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Targeted Antitumor Drugs in 2023
        3.5.3 Global Concentration Ratios (CR8) for Targeted Antitumor Drugs in 2023
    3.6 Targeted Antitumor Drugs Market: Overall Company Footprint Analysis
        3.6.1 Targeted Antitumor Drugs Market: Region Footprint
        3.6.2 Targeted Antitumor Drugs Market: Company Product Type Footprint
        3.6.3 Targeted Antitumor Drugs Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Targeted Antitumor Drugs Production Value Comparison
        4.1.1 United States VS China: Targeted Antitumor Drugs Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Targeted Antitumor Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Targeted Antitumor Drugs Production Comparison
        4.2.1 United States VS China: Targeted Antitumor Drugs Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Targeted Antitumor Drugs Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Targeted Antitumor Drugs Consumption Comparison
        4.3.1 United States VS China: Targeted Antitumor Drugs Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Targeted Antitumor Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Targeted Antitumor Drugs Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Targeted Antitumor Drugs Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Targeted Antitumor Drugs Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Targeted Antitumor Drugs Production (2019-2024)
    4.5 China Based Targeted Antitumor Drugs Manufacturers and Market Share
        4.5.1 China Based Targeted Antitumor Drugs Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Targeted Antitumor Drugs Production Value (2019-2024)
        4.5.3 China Based Manufacturers Targeted Antitumor Drugs Production (2019-2024)
    4.6 Rest of World Based Targeted Antitumor Drugs Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Targeted Antitumor Drugs Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Targeted Antitumor Drugs Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Targeted Antitumor Drugs Production (2019-2024)

5 Market Analysis by Type
    5.1 World Targeted Antitumor Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Injection
        5.2.2 Tablet
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Targeted Antitumor Drugs Production by Type (2019-2030)
        5.3.2 World Targeted Antitumor Drugs Production Value by Type (2019-2030)
        5.3.3 World Targeted Antitumor Drugs Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Targeted Antitumor Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Lung Cancer
        6.2.2 Lymphoma
        6.2.3 Breast Cancer
        6.2.4 Leukaemia
        6.2.5 Prostate Cancer
        6.2.6 Multiple Bone Marrow Cancer
        6.2.7 Others
    6.3 Market Segment by Application
        6.3.1 World Targeted Antitumor Drugs Production by Application (2019-2030)
        6.3.2 World Targeted Antitumor Drugs Production Value by Application (2019-2030)
        6.3.3 World Targeted Antitumor Drugs Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Roche
        7.1.1 Roche Details
        7.1.2 Roche Major Business
        7.1.3 Roche Targeted Antitumor Drugs Product and Services
        7.1.4 Roche Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Roche Recent Developments/Updates
        7.1.6 Roche Competitive Strengths & Weaknesses
    7.2 Celgene
        7.2.1 Celgene Details
        7.2.2 Celgene Major Business
        7.2.3 Celgene Targeted Antitumor Drugs Product and Services
        7.2.4 Celgene Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Celgene Recent Developments/Updates
        7.2.6 Celgene Competitive Strengths & Weaknesses
    7.3 Novartis
        7.3.1 Novartis Details
        7.3.2 Novartis Major Business
        7.3.3 Novartis Targeted Antitumor Drugs Product and Services
        7.3.4 Novartis Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Novartis Recent Developments/Updates
        7.3.6 Novartis Competitive Strengths & Weaknesses
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Details
        7.4.2 Johnson & Johnson Major Business
        7.4.3 Johnson & Johnson Targeted Antitumor Drugs Product and Services
        7.4.4 Johnson & Johnson Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Johnson & Johnson Recent Developments/Updates
        7.4.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.5 Lilly
        7.5.1 Lilly Details
        7.5.2 Lilly Major Business
        7.5.3 Lilly Targeted Antitumor Drugs Product and Services
        7.5.4 Lilly Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Lilly Recent Developments/Updates
        7.5.6 Lilly Competitive Strengths & Weaknesses
    7.6 AstraZeneca plc.
        7.6.1 AstraZeneca plc. Details
        7.6.2 AstraZeneca plc. Major Business
        7.6.3 AstraZeneca plc. Targeted Antitumor Drugs Product and Services
        7.6.4 AstraZeneca plc. Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 AstraZeneca plc. Recent Developments/Updates
        7.6.6 AstraZeneca plc. Competitive Strengths & Weaknesses
    7.7 Betta Pharmaceuticals
        7.7.1 Betta Pharmaceuticals Details
        7.7.2 Betta Pharmaceuticals Major Business
        7.7.3 Betta Pharmaceuticals Targeted Antitumor Drugs Product and Services
        7.7.4 Betta Pharmaceuticals Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Betta Pharmaceuticals Recent Developments/Updates
        7.7.6 Betta Pharmaceuticals Competitive Strengths & Weaknesses
    7.8 Shanghai Henlius Biopharmaceutical
        7.8.1 Shanghai Henlius Biopharmaceutical Details
        7.8.2 Shanghai Henlius Biopharmaceutical Major Business
        7.8.3 Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Product and Services
        7.8.4 Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Shanghai Henlius Biopharmaceutical Recent Developments/Updates
        7.8.6 Shanghai Henlius Biopharmaceutical Competitive Strengths & Weaknesses
    7.9 Innovent Biologics
        7.9.1 Innovent Biologics Details
        7.9.2 Innovent Biologics Major Business
        7.9.3 Innovent Biologics Targeted Antitumor Drugs Product and Services
        7.9.4 Innovent Biologics Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Innovent Biologics Recent Developments/Updates
        7.9.6 Innovent Biologics Competitive Strengths & Weaknesses
    7.10 Nanjing Shunxin Pharmaceuticals
        7.10.1 Nanjing Shunxin Pharmaceuticals Details
        7.10.2 Nanjing Shunxin Pharmaceuticals Major Business
        7.10.3 Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Product and Services
        7.10.4 Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Nanjing Shunxin Pharmaceuticals Recent Developments/Updates
        7.10.6 Nanjing Shunxin Pharmaceuticals Competitive Strengths & Weaknesses
    7.11 CSPC OUYI Pharmaceutical
        7.11.1 CSPC OUYI Pharmaceutical Details
        7.11.2 CSPC OUYI Pharmaceutical Major Business
        7.11.3 CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Product and Services
        7.11.4 CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 CSPC OUYI Pharmaceutical Recent Developments/Updates
        7.11.6 CSPC OUYI Pharmaceutical Competitive Strengths & Weaknesses
    7.12 Qilu Pharmaceutical
        7.12.1 Qilu Pharmaceutical Details
        7.12.2 Qilu Pharmaceutical Major Business
        7.12.3 Qilu Pharmaceutical Targeted Antitumor Drugs Product and Services
        7.12.4 Qilu Pharmaceutical Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Qilu Pharmaceutical Recent Developments/Updates
        7.12.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
    7.13 Shenzhen Salubris Pharmaceuticals
        7.13.1 Shenzhen Salubris Pharmaceuticals Details
        7.13.2 Shenzhen Salubris Pharmaceuticals Major Business
        7.13.3 Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Product and Services
        7.13.4 Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Shenzhen Salubris Pharmaceuticals Recent Developments/Updates
        7.13.6 Shenzhen Salubris Pharmaceuticals Competitive Strengths & Weaknesses
    7.14 Yaopharma
        7.14.1 Yaopharma Details
        7.14.2 Yaopharma Major Business
        7.14.3 Yaopharma Targeted Antitumor Drugs Product and Services
        7.14.4 Yaopharma Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Yaopharma Recent Developments/Updates
        7.14.6 Yaopharma Competitive Strengths & Weaknesses
    7.15 Lianyungang Runzhong Pharmaceutical
        7.15.1 Lianyungang Runzhong Pharmaceutical Details
        7.15.2 Lianyungang Runzhong Pharmaceutical Major Business
        7.15.3 Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Product and Services
        7.15.4 Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 Lianyungang Runzhong Pharmaceutical Recent Developments/Updates
        7.15.6 Lianyungang Runzhong Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Targeted Antitumor Drugs Industry Chain
    8.2 Targeted Antitumor Drugs Upstream Analysis
        8.2.1 Targeted Antitumor Drugs Core Raw Materials
        8.2.2 Main Manufacturers of Targeted Antitumor Drugs Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Targeted Antitumor Drugs Production Mode
    8.6 Targeted Antitumor Drugs Procurement Model
    8.7 Targeted Antitumor Drugs Industry Sales Model and Sales Channels
        8.7.1 Targeted Antitumor Drugs Sales Model
        8.7.2 Targeted Antitumor Drugs Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Targeted Antitumor Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Targeted Antitumor Drugs Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Targeted Antitumor Drugs Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Targeted Antitumor Drugs Production Value Market Share by Region (2019-2024)
    Table 5. World Targeted Antitumor Drugs Production Value Market Share by Region (2025-2030)
    Table 6. World Targeted Antitumor Drugs Production by Region (2019-2024) & (K Units)
    Table 7. World Targeted Antitumor Drugs Production by Region (2025-2030) & (K Units)
    Table 8. World Targeted Antitumor Drugs Production Market Share by Region (2019-2024)
    Table 9. World Targeted Antitumor Drugs Production Market Share by Region (2025-2030)
    Table 10. World Targeted Antitumor Drugs Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Targeted Antitumor Drugs Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Targeted Antitumor Drugs Major Market Trends
    Table 13. World Targeted Antitumor Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Targeted Antitumor Drugs Consumption by Region (2019-2024) & (K Units)
    Table 15. World Targeted Antitumor Drugs Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Targeted Antitumor Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Targeted Antitumor Drugs Producers in 2023
    Table 18. World Targeted Antitumor Drugs Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Targeted Antitumor Drugs Producers in 2023
    Table 20. World Targeted Antitumor Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Targeted Antitumor Drugs Company Evaluation Quadrant
    Table 22. World Targeted Antitumor Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Targeted Antitumor Drugs Production Site of Key Manufacturer
    Table 24. Targeted Antitumor Drugs Market: Company Product Type Footprint
    Table 25. Targeted Antitumor Drugs Market: Company Product Application Footprint
    Table 26. Targeted Antitumor Drugs Competitive Factors
    Table 27. Targeted Antitumor Drugs New Entrant and Capacity Expansion Plans
    Table 28. Targeted Antitumor Drugs Mergers & Acquisitions Activity
    Table 29. United States VS China Targeted Antitumor Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Targeted Antitumor Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Targeted Antitumor Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Targeted Antitumor Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Targeted Antitumor Drugs Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Targeted Antitumor Drugs Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Targeted Antitumor Drugs Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Targeted Antitumor Drugs Production Market Share (2019-2024)
    Table 37. China Based Targeted Antitumor Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Targeted Antitumor Drugs Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Targeted Antitumor Drugs Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Targeted Antitumor Drugs Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Targeted Antitumor Drugs Production Market Share (2019-2024)
    Table 42. Rest of World Based Targeted Antitumor Drugs Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Targeted Antitumor Drugs Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Targeted Antitumor Drugs Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Targeted Antitumor Drugs Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Targeted Antitumor Drugs Production Market Share (2019-2024)
    Table 47. World Targeted Antitumor Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Targeted Antitumor Drugs Production by Type (2019-2024) & (K Units)
    Table 49. World Targeted Antitumor Drugs Production by Type (2025-2030) & (K Units)
    Table 50. World Targeted Antitumor Drugs Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Targeted Antitumor Drugs Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Targeted Antitumor Drugs Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Targeted Antitumor Drugs Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Targeted Antitumor Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Targeted Antitumor Drugs Production by Application (2019-2024) & (K Units)
    Table 56. World Targeted Antitumor Drugs Production by Application (2025-2030) & (K Units)
    Table 57. World Targeted Antitumor Drugs Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Targeted Antitumor Drugs Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Targeted Antitumor Drugs Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Targeted Antitumor Drugs Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Roche Basic Information, Manufacturing Base and Competitors
    Table 62. Roche Major Business
    Table 63. Roche Targeted Antitumor Drugs Product and Services
    Table 64. Roche Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Roche Recent Developments/Updates
    Table 66. Roche Competitive Strengths & Weaknesses
    Table 67. Celgene Basic Information, Manufacturing Base and Competitors
    Table 68. Celgene Major Business
    Table 69. Celgene Targeted Antitumor Drugs Product and Services
    Table 70. Celgene Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Celgene Recent Developments/Updates
    Table 72. Celgene Competitive Strengths & Weaknesses
    Table 73. Novartis Basic Information, Manufacturing Base and Competitors
    Table 74. Novartis Major Business
    Table 75. Novartis Targeted Antitumor Drugs Product and Services
    Table 76. Novartis Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Novartis Recent Developments/Updates
    Table 78. Novartis Competitive Strengths & Weaknesses
    Table 79. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 80. Johnson & Johnson Major Business
    Table 81. Johnson & Johnson Targeted Antitumor Drugs Product and Services
    Table 82. Johnson & Johnson Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Johnson & Johnson Recent Developments/Updates
    Table 84. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 85. Lilly Basic Information, Manufacturing Base and Competitors
    Table 86. Lilly Major Business
    Table 87. Lilly Targeted Antitumor Drugs Product and Services
    Table 88. Lilly Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Lilly Recent Developments/Updates
    Table 90. Lilly Competitive Strengths & Weaknesses
    Table 91. AstraZeneca plc. Basic Information, Manufacturing Base and Competitors
    Table 92. AstraZeneca plc. Major Business
    Table 93. AstraZeneca plc. Targeted Antitumor Drugs Product and Services
    Table 94. AstraZeneca plc. Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. AstraZeneca plc. Recent Developments/Updates
    Table 96. AstraZeneca plc. Competitive Strengths & Weaknesses
    Table 97. Betta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 98. Betta Pharmaceuticals Major Business
    Table 99. Betta Pharmaceuticals Targeted Antitumor Drugs Product and Services
    Table 100. Betta Pharmaceuticals Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. Betta Pharmaceuticals Recent Developments/Updates
    Table 102. Betta Pharmaceuticals Competitive Strengths & Weaknesses
    Table 103. Shanghai Henlius Biopharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 104. Shanghai Henlius Biopharmaceutical Major Business
    Table 105. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Product and Services
    Table 106. Shanghai Henlius Biopharmaceutical Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Shanghai Henlius Biopharmaceutical Recent Developments/Updates
    Table 108. Shanghai Henlius Biopharmaceutical Competitive Strengths & Weaknesses
    Table 109. Innovent Biologics Basic Information, Manufacturing Base and Competitors
    Table 110. Innovent Biologics Major Business
    Table 111. Innovent Biologics Targeted Antitumor Drugs Product and Services
    Table 112. Innovent Biologics Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. Innovent Biologics Recent Developments/Updates
    Table 114. Innovent Biologics Competitive Strengths & Weaknesses
    Table 115. Nanjing Shunxin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 116. Nanjing Shunxin Pharmaceuticals Major Business
    Table 117. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Product and Services
    Table 118. Nanjing Shunxin Pharmaceuticals Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. Nanjing Shunxin Pharmaceuticals Recent Developments/Updates
    Table 120. Nanjing Shunxin Pharmaceuticals Competitive Strengths & Weaknesses
    Table 121. CSPC OUYI Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 122. CSPC OUYI Pharmaceutical Major Business
    Table 123. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Product and Services
    Table 124. CSPC OUYI Pharmaceutical Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. CSPC OUYI Pharmaceutical Recent Developments/Updates
    Table 126. CSPC OUYI Pharmaceutical Competitive Strengths & Weaknesses
    Table 127. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 128. Qilu Pharmaceutical Major Business
    Table 129. Qilu Pharmaceutical Targeted Antitumor Drugs Product and Services
    Table 130. Qilu Pharmaceutical Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 131. Qilu Pharmaceutical Recent Developments/Updates
    Table 132. Qilu Pharmaceutical Competitive Strengths & Weaknesses
    Table 133. Shenzhen Salubris Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 134. Shenzhen Salubris Pharmaceuticals Major Business
    Table 135. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Product and Services
    Table 136. Shenzhen Salubris Pharmaceuticals Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 137. Shenzhen Salubris Pharmaceuticals Recent Developments/Updates
    Table 138. Shenzhen Salubris Pharmaceuticals Competitive Strengths & Weaknesses
    Table 139. Yaopharma Basic Information, Manufacturing Base and Competitors
    Table 140. Yaopharma Major Business
    Table 141. Yaopharma Targeted Antitumor Drugs Product and Services
    Table 142. Yaopharma Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 143. Yaopharma Recent Developments/Updates
    Table 144. Lianyungang Runzhong Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 145. Lianyungang Runzhong Pharmaceutical Major Business
    Table 146. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Product and Services
    Table 147. Lianyungang Runzhong Pharmaceutical Targeted Antitumor Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 148. Global Key Players of Targeted Antitumor Drugs Upstream (Raw Materials)
    Table 149. Targeted Antitumor Drugs Typical Customers
    Table 150. Targeted Antitumor Drugs Typical Distributors
List of Figure
    Figure 1. Targeted Antitumor Drugs Picture
    Figure 2. World Targeted Antitumor Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Targeted Antitumor Drugs Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Targeted Antitumor Drugs Production (2019-2030) & (K Units)
    Figure 5. World Targeted Antitumor Drugs Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Targeted Antitumor Drugs Production Value Market Share by Region (2019-2030)
    Figure 7. World Targeted Antitumor Drugs Production Market Share by Region (2019-2030)
    Figure 8. North America Targeted Antitumor Drugs Production (2019-2030) & (K Units)
    Figure 9. Europe Targeted Antitumor Drugs Production (2019-2030) & (K Units)
    Figure 10. China Targeted Antitumor Drugs Production (2019-2030) & (K Units)
    Figure 11. Japan Targeted Antitumor Drugs Production (2019-2030) & (K Units)
    Figure 12. Targeted Antitumor Drugs Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Targeted Antitumor Drugs Consumption (2019-2030) & (K Units)
    Figure 15. World Targeted Antitumor Drugs Consumption Market Share by Region (2019-2030)
    Figure 16. United States Targeted Antitumor Drugs Consumption (2019-2030) & (K Units)
    Figure 17. China Targeted Antitumor Drugs Consumption (2019-2030) & (K Units)
    Figure 18. Europe Targeted Antitumor Drugs Consumption (2019-2030) & (K Units)
    Figure 19. Japan Targeted Antitumor Drugs Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Targeted Antitumor Drugs Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Targeted Antitumor Drugs Consumption (2019-2030) & (K Units)
    Figure 22. India Targeted Antitumor Drugs Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Targeted Antitumor Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Targeted Antitumor Drugs Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Targeted Antitumor Drugs Markets in 2023
    Figure 26. United States VS China: Targeted Antitumor Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Targeted Antitumor Drugs Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Targeted Antitumor Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Targeted Antitumor Drugs Production Market Share 2023
    Figure 30. China Based Manufacturers Targeted Antitumor Drugs Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Targeted Antitumor Drugs Production Market Share 2023
    Figure 32. World Targeted Antitumor Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Targeted Antitumor Drugs Production Value Market Share by Type in 2023
    Figure 34. Injection
    Figure 35. Tablet
    Figure 36. Others
    Figure 37. World Targeted Antitumor Drugs Production Market Share by Type (2019-2030)
    Figure 38. World Targeted Antitumor Drugs Production Value Market Share by Type (2019-2030)
    Figure 39. World Targeted Antitumor Drugs Average Price by Type (2019-2030) & (US$/Unit)
    Figure 40. World Targeted Antitumor Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 41. World Targeted Antitumor Drugs Production Value Market Share by Application in 2023
    Figure 42. Lung Cancer
    Figure 43. Lymphoma
    Figure 44. Breast Cancer
    Figure 45. Leukaemia
    Figure 46. Prostate Cancer
    Figure 47. Multiple Bone Marrow Cancer
    Figure 48. Others
    Figure 49. World Targeted Antitumor Drugs Production Market Share by Application (2019-2030)
    Figure 50. World Targeted Antitumor Drugs Production Value Market Share by Application (2019-2030)
    Figure 51. World Targeted Antitumor Drugs Average Price by Application (2019-2030) & (US$/Unit)
    Figure 52. Targeted Antitumor Drugs Industry Chain
    Figure 53. Targeted Antitumor Drugs Procurement Model
    Figure 54. Targeted Antitumor Drugs Sales Model
    Figure 55. Targeted Antitumor Drugs Sales Channels, Direct Sales, and Distribution
    Figure 56. Methodology
    Figure 57. Research Process and Data Source

Companies Mentioned

Roche
Celgene
Novartis
Johnson & Johnson
Lilly
AstraZeneca plc.
Betta Pharmaceuticals
Shanghai Henlius Biopharmaceutical
Innovent Biologics
Nanjing Shunxin Pharmaceuticals
CSPC OUYI Pharmaceutical
Qilu Pharmaceutical
Shenzhen Salubris Pharmaceuticals
Yaopharma
Lianyungang Runzhong Pharmaceutical